Corona Remedies shares to list on Monday; GMP signals solid listing. Check price and other key details here

Corona Remedies is set to debut on December 15 after its IPO attracted massive interest, with a subscription rate of 144 times. The shares are currently trading at a grey market premium of ₹291, indicating an estimated listing price of ₹1,353 per share.